Praxis Precision Medicines, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 37.46 million compared to USD 68.72 million a year ago. Basic loss per share from continuing operations was USD 10.65 compared to USD 22.65 a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
47.02 USD | +4.47% | +2.46% | +111.09% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+111.09% | 770M | |
+41.67% | 54.04B | |
+43.57% | 41.96B | |
-1.13% | 41.92B | |
-7.59% | 28.35B | |
+12.22% | 26.35B | |
-22.41% | 19B | |
+7.84% | 13B | |
+29.16% | 12.28B | |
+25.14% | 12.19B |
- Stock Market
- Equities
- PRAX Stock
- News Praxis Precision Medicines, Inc.
- Praxis Precision Medicines, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023